D-1460-2016 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1460-2016 was initiated by Zydus Pharmaceuticals USA Inc on Jul 19, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications: out of specification dissolution results in retained samples The recall status is terminated (terminated Sep 21, 2020). Affected quantity: 223,776 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 24, 2016
Initiation Date
Jul 19, 2016
Termination Date
Sep 21, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
223,776 bottles

Product description

Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534.

Reason for recall

Failed Dissolution Specifications: out of specification dissolution results in retained samples

Distribution pattern

Nationwide

Code information

Lot #: a) MR10518, Exp. 9/2017; MR11051, MR11052, MR11053, MR11054, Exp. 10/2017; MR11403, Exp. 11/2017. Lot #: b) MR10197, MR10195, Exp. 09/2017; MR11482, Exp.10/2017; MR11479, MR11480, MR11481, MR11483, MR11665 Exp. 11/2017. Lot #: c) MR10404, MR10406, MR10521, Exp. 09/2017; MR10744, MR11055, MR11228, MR11287, MR11285, MR11288, MR11289, MR11286, Exp.10/2017; MR11567, Exp.11/2017.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1460-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1460-2016. Report a data issue: hello@regdatalab.com.